19 results
425
SLXN
Biomotion Sciences Ordinary Shares
25 Jul 24
Business combination disclosure
4:05pm
run - in Phase 2 expanded Phase 3 21 World - Renowned Expert Scientific Advisory Board Eileen M. O'Reilly, MD Memorial Sloan Kettering, NY, NY
425
MACA
Moringa Acquisition Corp
25 Jul 24
Business combination disclosure
4:05pm
World - Renowned Expert Scientific Advisory Board Eileen M. O'Reilly, MD Memorial Sloan Kettering, NY, NY Winthrop Rockefeller Endowed Chair
DEFM14A
MACA
Moringa Acquisition Corp
17 Jul 24
Proxy related to merger
9:13am
. Brachfeld qualifies as an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management
PRE 14A
azl kt4f66271tonnfu
15 Dec 22
Preliminary proxy
5:18pm
10-K
2g0cuja lb9
31 Mar 21
Annual report
5:15pm
8-K
EX-10.10
a2go73 6u
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.6
zvfnbj
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.8
ciy3v 0em
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.12
u6rs9nl7gz96j
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.7
tur0mn3bdx 76qkck5nl
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.9
8ffy8svhm93wujt9iwa
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
8-K
EX-10.11
o1v1ms2y4xnhb7m353
22 Feb 21
Moringa Acquisition Corp Announces Pricing of $100 Million Initial Public Offering
4:20pm
424B4
0k0g5
17 Feb 21
Prospectus supplement with pricing info
11:53am
S-1
oibwxx69rxhe
1 Feb 21
IPO registration
4:12pm
S-1
EX-10.7
d87nourc 6jrems
1 Feb 21
IPO registration
4:12pm
DRS
grdjzgzrjo1f rvxkj
22 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next